Amphetamine designer drugs are central nervous system stimulants widely diffused worldwide in illegal markets. Their identification is often difficult, because of the high structural variety of new compounds. Monitoring of drugs of abuse in biological fluids is successfully used for clinical and forensic applications.In this work a method for identify and quantify 3,4-methylenedioxy-N-isopropylamphetamine (MDIP), 3,4-methylenedioxy-N-cyclopropylmethylamphetamine (MDCPM), 3,4-methylenedioxy-N-benzylamphetamine (MDBZ) and 3,4-methylenedioxy-N-ethylamphetamine (MDE) in urine, and a method for identify and quantify 4-bromo-2,5,beta-trimethoxyphenethylamine (BOB), 4-methyl-2,5,beta-trimethoxyphenethylamine (BOD), 3,4-methylenedioxy-beta-methoxyphenethylamine (BOH) and 4-methyl-2,5-dimethoxy-beta-hydroxyphenethylamine (BOHD) in plasma are described.In addition, the cross-reactivity profiles of 41 new amphetamines to 6 commonly used screening tests for urine and oral fluid are reported.Furthermore an easy-to-prepare chiral CE method for the enantiomeric separation of 13 new amphetamine-like designer drugs using cyclodextrins as chiral selectors has been developed.

Metodi di screening, conferma e separazione enantiomerica di nuovi designer drugs amfetamino-simili / Burrai, Lucia. - (2014 Jan 31).

Metodi di screening, conferma e separazione enantiomerica di nuovi designer drugs amfetamino-simili

BURRAI, Lucia
2014-01-31

Abstract

Amphetamine designer drugs are central nervous system stimulants widely diffused worldwide in illegal markets. Their identification is often difficult, because of the high structural variety of new compounds. Monitoring of drugs of abuse in biological fluids is successfully used for clinical and forensic applications.In this work a method for identify and quantify 3,4-methylenedioxy-N-isopropylamphetamine (MDIP), 3,4-methylenedioxy-N-cyclopropylmethylamphetamine (MDCPM), 3,4-methylenedioxy-N-benzylamphetamine (MDBZ) and 3,4-methylenedioxy-N-ethylamphetamine (MDE) in urine, and a method for identify and quantify 4-bromo-2,5,beta-trimethoxyphenethylamine (BOB), 4-methyl-2,5,beta-trimethoxyphenethylamine (BOD), 3,4-methylenedioxy-beta-methoxyphenethylamine (BOH) and 4-methyl-2,5-dimethoxy-beta-hydroxyphenethylamine (BOHD) in plasma are described.In addition, the cross-reactivity profiles of 41 new amphetamines to 6 commonly used screening tests for urine and oral fluid are reported.Furthermore an easy-to-prepare chiral CE method for the enantiomeric separation of 13 new amphetamine-like designer drugs using cyclodextrins as chiral selectors has been developed.
31-gen-2014
Amphetamine-like designer drugs; quantitation; LC-MS; immunoassay; enantiomeric separation
Metodi di screening, conferma e separazione enantiomerica di nuovi designer drugs amfetamino-simili / Burrai, Lucia. - (2014 Jan 31).
File in questo prodotto:
File Dimensione Formato  
Burrai_L_Metodi_di_screening_conferma.pdf

accesso aperto

Tipologia: Altro materiale allegato
Licenza: Non specificato
Dimensione 3.75 MB
Formato Adobe PDF
3.75 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11388/250721
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact